Courtney W Hudgens

24PUBLICATIONS
221CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyFood properties (incl. characteristics and health benefits)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

|Sep 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.

Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira

|Jun 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Christopher P Vellano, Michael G White, Miles C Andrews

|Dec 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Christine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan

|Nov 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.

Michael G White, Robert Szczepaniak Sloane, Russell G Witt

Pageof 4

Frequent Collaborators

16 joint publications

Michael T Tetzlaff

12 joint publications

Alexander J Lazar

10 joint publications

James M Reuben

8 joint publications

Jennifer A Wargo